These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 25164620

  • 21. Imatinib (Glivec) and gastrointestinal stromal tumours in Nigerians.
    Durosinmi MA, Salawu L, Lawal OO, Ojo OS, Alatishe OI, Oyekunle AA, Bolarinwa RA, Adisa AO, Badmos K, Anomneze EE, Ayansanwo AO.
    Afr J Med Med Sci; 2013 Dec; 42(4):325-32. PubMed ID: 24839736
    [Abstract] [Full Text] [Related]

  • 22. Clinical significance of pathological complete response in patients with metastatic gastrointestinal stromal tumors after imatinib mesylate treatment--lessons learned.
    Cheng CT, Tsai CY, Yeh CN, Chiang KC, Chen YY, Wang SY, Chen TW, Tseng JH, Jung SM, Chen TC, Yeh TS.
    Anticancer Res; 2014 Nov; 34(11):6617-25. PubMed ID: 25368266
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).
    Bauer S, Rutkowski P, Hohenberger P, Miceli R, Fumagalli E, Siedlecki JA, Nguyen BP, Kerst M, Fiore M, Nyckowski P, Hoiczyk M, Cats A, Casali PG, Treckmann J, van Coevorden F, Gronchi A.
    Eur J Surg Oncol; 2014 Apr; 40(4):412-9. PubMed ID: 24491288
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor.
    Hamza I, Gaies E, Kastalli S, Daghfous R, El Aidli S.
    Therapie; 2014 Apr; 69(3):245-7. PubMed ID: 24934821
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy.
    Angelini S, Pantaleo MA, Ravegnini G, Zenesini C, Cavrini G, Nannini M, Fumagalli E, Palassini E, Saponara M, Di Battista M, Casali PG, Hrelia P, Cantelli-Forti G, Biasco G.
    Pharmacol Res; 2013 Feb; 68(1):1-6. PubMed ID: 23127916
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical experience of imatinib mesylate for metastatic or recurrent gastrointestinal stromal tumor].
    Toyokawa T, Yamashita Y, Yamamoto A, Shimizu S, Inoue T, Kanazawa A, Tsukamoto T, Ikehara T, Nishiguchi Y.
    Gan To Kagaku Ryoho; 2014 Jan; 41(1):55-8. PubMed ID: 24423952
    [Abstract] [Full Text] [Related]

  • 32. Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.
    DeMatteo RP, Ballman KV, Antonescu CR, Corless C, Kolesnikova V, von Mehren M, McCarter MD, Norton J, Maki RG, Pisters PW, Demetri GD, Brennan MF, Owzar K, American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team for the Alliance for Clinical Trials in Oncology.
    Ann Surg; 2013 Sep; 258(3):422-9. PubMed ID: 23860199
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
    Hanada N, Kawata K, Okamura S, Tomiyama N, Hori K.
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.